Difference between revisions of "Team:TAS Taipei/Human Practices"

 
(74 intermediate revisions by 5 users not shown)
Line 3: Line 3:
  
 
<head>
 
<head>
<title>Human Practice Summary - TAS Taipei iGEM Wiki</title>
+
<title>Human Practice - TAS Taipei iGEM Wiki</title>
 
  <style type='text/css'>
 
  <style type='text/css'>
 
       #top_title, #sideMenu{
 
       #top_title, #sideMenu{
Line 16: Line 16:
  
 
        
 
        
 
+
    img{width:100%}
  
 
     </style>
 
     </style>
Line 67: Line 67:
 
<ul style='margin-left:0px'>
 
<ul style='margin-left:0px'>
 
<li class="dropdown">
 
<li class="dropdown">
<a href="https://2016.igem.org/Team:TAS_Taipei/Description"><h4 class="dropdown-toggle disabled" data-toggle="dropdown"><b>PROJECT</b></h4></a>
+
<a href="https://2016.igem.org/Team:TAS_Taipei/Background"><h4 class="dropdown-toggle disabled" data-toggle="dropdown"><b>PROJECT</b></h4></a>
 
<div class="dropdown-menu">
 
<div class="dropdown-menu">
 
<div class='subcategories_container'>
 
<div class='subcategories_container'>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Description">Background</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Background">Background</a></h5>
 
</div>
 
</div>
 
<div>
 
<div>
Line 118: Line 118:
 
<div class='subcategories_container'>
 
<div class='subcategories_container'>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Model#crystallin">Cataract Damage</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Model#GSRFunc">GSR Function</a></h5>
 
</div>
 
</div>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Model#gsrch25h">GSR/CH25H Pathway</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Model#prototype">Prototype Delivery</a></h5>
 
</div>
 
</div>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Model#nanoparticle">Nanoparticle Delivery</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Model#treatment">CH25H Treatment</a></h5>
 
</div>
 
</div>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Model#eyedrop">Eyedrop Model</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Model#software">Calculator</a></h5>
 
</div>
 
</div>
  
Line 138: Line 138:
 
</li>
 
</li>
 
<li class="dropdown">
 
<li class="dropdown">
<a href="https://2016.igem.org/Team:TAS_Taipei/Practices"><h4 class='dropdown-toggle disabled' data-toggle="dropdown"><b>HUMAN PRACTICE</b></h4></a>
+
<a href="https://2016.igem.org/Team:TAS_Taipei/Human_Practices"><h4 class='dropdown-toggle disabled' data-toggle="dropdown"><b>HUMAN PRACTICE</b></h4></a>
 
<div class="dropdown-menu">
 
<div class="dropdown-menu">
 
<div class='subcategories_container'>
 
<div class='subcategories_container'>
Line 158: Line 158:
 
</li>
 
</li>
 
<li class="dropdown">
 
<li class="dropdown">
<a href="https://2016.igem.org/Team:TAS_Taipei/Safety"><h4 class='dropdown-toggle disabled' data-toggle="dropdown"><b>BIOSAFETY</b></h4></a>
+
<a href="https://2016.igem.org/Team:TAS_Taipei/Safety"><h4 class='dropdown-toggle disabled' data-toggle="dropdown"><b>SAFETY</b></h4></a>
 
<div class="dropdown-menu">
 
<div class="dropdown-menu">
 
<div style='height:100px;'>
 
<div style='height:100px;'>
 
<div class='subcategories_container'>
 
<div class='subcategories_container'>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Safety#researcher_safety">Researcher Safety</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Safety#overview">Overview</a></h5>
 
</div>
 
</div>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Safety#environmental_safety">Environmental Safety</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Safety#biosafety">Biosafety</a></h5>
 
</div>
 
</div>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Safety#biobrick_safety">Biobrick Safety</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Safety#riskreduction">Risk Reduction Methods</a></h5>
 
</div>
 
</div>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Safety#local_safety">Local Safety</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Safety#furtherquestion">Further Questions</a></h5>
 
</div>
 
</div>
 
</div>
 
</div>
Line 188: Line 188:
 
</div>
 
</div>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/team#tas">About</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Team#about">About</a></h5>
 
</div>
 
</div>
 
<div>
 
<div>
Line 194: Line 194:
 
</div>
 
</div>
 
<div>
 
<div>
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Standard_Pages">Wiki Standard Pages</a></h5>
+
<h5><a href="https://2016.igem.org/Team:TAS_Taipei/Wiki_Standard_Pages">Wiki Standard Pages</a></h5>
 
</div>
 
</div>
 
</div>
 
</div>
Line 209: Line 209:
 
<br>
 
<br>
 
<br>
 
<br>
<div class="row center-block" style = "padding:10px;width:960px;background-color:#07BEB8;box-shadow:0px 0px 5px black">
+
<div class="row center-block" style = "padding:10px;width:90%;background-color:#07BEB8;box-shadow:0px 0px 5px black">
 
<div class="row" style = "text-align:center;">
 
<div class="row" style = "text-align:center;">
 
<div class="col-sm-2">
 
<div class="col-sm-2">
Line 231: Line 231:
 
<div id="category_navbar">
 
<div id="category_navbar">
 
<ul class="nav nav-list" data-spy="affix" data-offset-top="160" style='-webkit-transform: translateZ(0);width:160px;margin-left:0' >
 
<ul class="nav nav-list" data-spy="affix" data-offset-top="160" style='-webkit-transform: translateZ(0);width:160px;margin-left:0' >
<li><a href="#lensmodel">Lens Cataract Model</a></li>
+
<li><a href="#research">Research</a></li>
 
                         <ul>
 
                         <ul>
                             <li> <a href="#LensPrevention">Prevention</a></li>
+
                             <li> <a href="#professional">Professional Help</a></li>
                             <li> <a href="#LensTreatment">Treatment</a></li>
+
                             <li> <a href="#public">Public Opinion</a></li>
 
                         </ul>
 
                         </ul>
<li><a href="#construct">Construct</a></li>
+
<li><a href="#outreach">Outreach</a></li>
 +
                        <li><a href="#impact">Impact</a></li>
 
                         <ul>
 
                         <ul>
                             <li> <a href="#ConstructPrevention">Prevention</a></li>
+
                             <li> <a href="#marketing">Marketing Plan</a></li>
                             <li> <a href="#ConstructTreatment">Treatment</a></li>
+
                             <li> <a href="#fundraising">Fundraising</a></li>
                        </ul>
+
                        <li><a href="#prototype">Delivery Prototype</a></li>
+
                        <ul>
+
                            <li> <a href="#step1">Purification</a></li>
+
                            <li> <a href="#step2">Nanoparticle</a></li>
+
                            <li> <a href="#step2i">Encapsulation</a></li>
+
                            <li> <a href="#step2ii">Release</a></li>
+
                            <li> <a href="#step3">Application</a></li>
+
 
                         </ul>
 
                         </ul>
 
</ul>
 
</ul>
Line 259: Line 252:
 
                     <div class = "row">
 
                     <div class = "row">
 
              <div class="col-sm-12">
 
              <div class="col-sm-12">
        <h2 id = 'lensmodel'>Introduction</h2>
+
                           
 
                             <div class="row">
 
                             <div class="row">
                                 <div class="col-sm-12">
+
                               
                                <p>
+
                                 <div class="col-sm-9">
                                     A project without direction and impact is not something that will be relevant in the eyes of the public. The goal of the policy and practice portion of our project is to ensure that we are headed in the right direction in terms of our project’s global impact and relevance. We have gathered data from researchers, medical doctors, veterinarians, cataract patients and public opinions to find out the best way to develop our project so that it can benefit as many people as possible.
+
                                    <p>
 +
                                     What we discovered through our findings in policy and practice helped shaped the trajectory of our project. We gathered data from researchers, medical doctors, veterinarians, cataract patients, and public opinions to find out the best way to develop our project so that it can benefit as many people as possible.
 
                                 </p>
 
                                 </p>
                                </div>
 
                            </div>
 
                            <div class="row">
 
                                <div class="col-sm-12">
 
 
                                 <p>
 
                                 <p>
                                     Our Policy and Practice is separated into three categories, Research, Outreach and Impact. In the Research category, we collect and analyze all of the data from researchers, doctors, vets, investors, and the general public. This information shapes the direction of every part of our project, including the construct design, nanoparticle prototype synthesis and delivery, biological modeling and the development of a marketing plan for selling our final product. In the Outreach category, we educated the public and spread awareness of our cataracts project, synthetic biology and science in general.  We have also collaborated and communicated with several iGEM teams to help solve problems together.  Through educating and raising awareness, we hope not only to get more people involved in finding a solution to cataracts, but also to get more people involved and interested in synthetic biology research. The final category, Impact, includes working with organizations and infrastructure that is already in place to actually help people who suffer from Cataracts. We have raised funds, through bake sales and other events, to donate to the Himalayan Cataracts Project, a non-profit organization based in Nepal.  With the help of our business and economics teacher, we have also created a marketing plan and started discussions with several biotech investors about the possibility of getting our project to market.
+
                                     Our Policy and Practice is separated into three categories, <b>Research, Outreach and Impact</b>. In the Research category, we collected and analyzed data from researchers, doctors, vets, investors, patients and the general public. This information shaped the direction of every part of our project, including the construct design, nanoparticle prototype synthesis and delivery, biological modeling and the development of a marketing plan for selling our final product. In the Outreach category, we educated the public and spread awareness of our cataracts project, synthetic biology and science in general.  We also collaborated and communicated with two iGEM teams to help solve problems together.  Through educating and raising awareness, we hope not only to get more people involved in finding a solution to cataracts, but also to get more people involved and interested in synthetic biology research. The final category, Impact, includes working with organizations and infrastructure that is already in place to actually help people who suffer from Cataracts. We have raised funds, through bake sales and other events, to donate to the Himalayan Cataracts Project, a non-profit organization based in Nepal.  With the help of our business and economics teacher, we have also created a marketing plan and started discussions with several biotech investors about the possibility of getting our project to market.
 
                                 </p>
 
                                 </p>
 +
                                </div>
 +
                                <div class="col-sm-3">
 +
                                    <div class="col-sm-10">
 +
                                    <img src="https://static.igem.org/mediawiki/2016/4/4f/T--TAS_Taipei--Best_Engagement.png">
 +
                                    <img src="https://static.igem.org/mediawiki/2016/a/ac/T--TAS_Taipei--Best_Integrated.png">
 +
                                    </div>
 
                                 </div>
 
                                 </div>
 
                             </div>
 
                             </div>
                   
 
                             
 
                            <br><br>
 
 
                          
 
                          
  
Line 285: Line 278:
 
                   <div class = "row">
 
                   <div class = "row">
 
              <div class="col-sm-12">
 
              <div class="col-sm-12">
        <h2 id = 'construct'>Research</h2>
+
        <h2 id = 'research'>Research</h2>
 
                             <div class="row">
 
                             <div class="row">
 
                                  
 
                                  
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
                                 <h3 id="ConstructPrevention"></h3>
+
                                 <h3 id="professional"></h3>
 
                                     <br>
 
                                     <br>
 
                                 <h3>Professional Help</h3>
 
                                 <h3>Professional Help</h3>
 
                                 <p>
 
                                 <p>
                                     In order to improve how we develop our prototype we needed to get in contact with experts in the fields of eye surgery and cataracts research. Our first step was to contact eye doctors to discuss any problems associated with current cataracts treatment. Finally, while developing our project we realized that cataracts is a major issue in pets and other animals as well as people. As a result, we contacted local veterinarians to discuss what pet owners do when their pets contract cataracts. As our project developed, we needed more specific information regarding our genes of interest, cataracts development, and our delivery mechanism. We contacted scientists doing research similar to our own to get their opinion on our projects progress.
+
                                     In order to improve our research and prototype, we needed to get in contact with experts in the fields of eye surgery and cataract research. Our first step was to contact eye doctors to discuss any problems associated with current cataract treatments. Finally, while developing our project we realized that cataracts are a major issue in pets and other animals as well. As a result, we contacted local veterinarians to discuss what pet owners do when their pets develop cataracts. As our project developed, we needed more specific information regarding our genes of interest, cataract development, and our delivery mechanism. We contacted scientists doing research similar to our own to get their opinions on our projects as well.
 
                                 </p>
 
                                 </p>
 
                                 </div>
 
                                 </div>
 
                                  
 
                                  
 
                             </div>
 
                             </div>
                           <br><br>
+
                           <br>
 
                             <div class="row">
 
                             <div class="row">
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
Line 305: Line 298:
 
                                     <h4>Contact with Eye Doctors</h4>
 
                                     <h4>Contact with Eye Doctors</h4>
 
                                     <p>
 
                                     <p>
                                         Eye doctors are on the front lines, delivering cataracts surgery, some privately and others for charity in organizations such as the Himalayan Cataracts Projects. We contacted local Taiwanese Eye Doctors to ask them about cataracts surgery. Here is a list of the doctors we contacted along with the information they provided:  
+
                                         We contacted local Taiwanese eye doctors to ask them about cataracts surgery. Here is a list of the doctors we contacted along with the information they provided:  
 
                                     </p>
 
                                     </p>
 
                                 </div>
 
                                 </div>
Line 312: Line 305:
 
                             </div>
 
                             </div>
 
                             <div class="row">
 
                             <div class="row">
                                <div class="col-sm-6">
 
                                    <h3 id="ConstructPrevention"></h3>
 
                                        <br>
 
                                    <p>
 
                                        Dr. Wei-Chi Wu is a retina specialist and an associate professor at Chang Gung memorial hospital in Taiwan. According to Dr. Wu current cataracts surgery methods are efficient and effective, but are not without their issues. Besides the issue of price, there can also be several different post-surgery complications such as infection, hemorrhaging, or secondary glaucoma. In regards to our project, he said one of the biggest issues we would face is non-invasive delivery. Currently, injections and incisions are the only methods for delivery because all current potential methods of noninvasive delivery either lack efficiency or induce with side effects.
 
                                    </p>
 
                                </div>
 
                                <figure class = "col-sm-6">
 
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
 
                                    <figcaption class='darkblue'><b>Figure X. </b>Full Construct.</figcaption>
 
                                </figure>
 
                               
 
                               
 
                            </div>
 
                          <br><br>
 
                            <div class="row">
 
                               
 
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
                               
+
                                    <div class="row">
                                <p>
+
                                        <figure class = "col-sm-3">
                                    Dr. Tsu Chieh Cheng is a optomologist at Chang cheng eye hospital in Taiwan. Dr. Cheng points out that aside from possibly causing complications such as astigmatism, myopia, and hyperopia, cataracts surgeries have risks, for wound infections, dislodgement of lens, and massive bleeding during surgeries aren’t uncommon. He remarked that our project sounded very promising, but the effect the drug has on other parts of the eyes must be checked. Furthermore, he suggested us to use rabbits or dogs as animal models, because they can be observed more easily.   
+
                                        <img src="https://static.igem.org/mediawiki/2016/3/3e/T--TAS_Taipei--Doctor1.png">
                                </p>
+
                                        </figure>
 +
                                        <div class="col-sm-3">
 +
                                            <p>
 +
                                              <b> Dr. Wei-Chi Wu</b> is a retina specialist and an associate professor at Chang Gung memorial hospital in Taiwan.
 +
                                            </p>
 +
                                        </div>
 +
                                        <figure class = "col-sm-3">
 +
                                        <img src="https://static.igem.org/mediawiki/2016/7/7d/T--TAS_Taipei--Doctor2.png">
 +
                                        </figure>
 +
                                        <div class="col-sm-3">
 +
                                            <p>
 +
                                                <b>Dr. Tsu Chieh Cheng </b>is a opthamologist at Chang Cheng eye hospital in Taiwan.
 +
                                            </p>
 +
                                        </div>
 +
                                    </div>
 +
                                    <br>
 +
                                    <div class="row">
 +
                                        <div class="col-sm-6">
 +
                                            <p>
 +
                                                According to Dr. Wu current cataract surgery methods are efficient and effective, but are not without their issues. Beside the high cost of surgery, there can also be several different post-surgery complications such as infection, hemorrhaging, or secondary glaucoma. In regards to our project, he said one of the biggest issues we would face is non-invasive delivery. Currently, injections and incisions are the only methods for delivery because all current potential methods of noninvasive delivery either lack efficiency or induce side effects. 
 +
                                            </p>
 +
                                        </div>
 +
                                        <div class="col-sm-6">
 +
                                            <p>
 +
                                                Dr. Cheng points out that aside from possibly causing complications such as astigmatism, myopia, and hyperopia, cataract surgeries have risks, such as wound infections, dislodgement of lens, and massive bleeding during surgeries are not uncommon. He remarked that our project sounded very promising, but the effect that the drug has on other parts of the eye must be checked. Furthermore, he suggested that we use rabbits or dogs as animal models, because they can be observed more easily.   
 +
                                            </p>
 +
                                        </div>
 +
                                    </div>
 
                                 </div>
 
                                 </div>
                               
+
                          </div>
                            </div>
+
                                               
                          <br><br>
+
 
                           <div class="row">
 
                           <div class="row">
                                 <div class="col-sm-12">
+
                             
                                    <h3 id="ConstructPrevention"></h3>
+
                                 <div class="col-sm-6">
                                        <br>
+
 
                                     <h4>Contact with Veterinarians</h4>
 
                                     <h4>Contact with Veterinarians</h4>
 +
                                   
 
                                     <p>
 
                                     <p>
                                         Cataracts trouble millions of people’s lives as a result of aging and diseases; however, many pet owners come across the problem of their pets suffering from cataracts as well. To alleviate this problem, the benefits of our solution for preventing and treating cataracts can be applied to domestic animals as well.
+
                                         Cataracts affect millions of people’s lives as a result of aging and diseases; however, many pet owners come across the problem of their pets suffering from cataracts as well. To alleviate this problem, we investigated if the potential benefits of our solution can be applied to domestic animals as well.
 
+
 
                                     </p>
 
                                     </p>
 
                                     <p>
 
                                     <p>
                                         As we continue to develop our project with consideration for the application on other animals, we realize that the slight dissimilarities among the lenses of different animals must be accounted for. Therefore, we consulted with veterinarians at clinics around Taipei. We visited two veterinarian clinics, and asked various others about relevant questions regarding the viability of our project solution. From the interviews we gained valuable insight on the eyedrops that pharmaceutical companies have developed to mitigate the cataracts in the lenses. One of the drugs developed is called Ocluvet(R).  
+
                                         As we continued to develop our project, we also hoped to treat cataracts in animals. We consulted with veterinarians at clinics around Taipei. We visited two veterinarian clinics, (Nicholas Animal Hospital and Tai Pu Veterinarian Hospital) and asked various others about the viability of our project. From these interviews we learned that there are already commercial eye drops available, which are prescribed for pets, but that these are not very effective. One of the drugs developed is called Ocluvet(R), which we purchased and used in our experiments to compare to our own treatment design.  
 +
 
 
                                     </p>
 
                                     </p>
 
                                 </div>
 
                                 </div>
                               
+
                              
                               
+
                              <figure class = "col-sm-6">
                             </div>
+
                                  <br>
                            <div class="row">
+
        <img src="https://static.igem.org/mediawiki/2016/0/04/T--TAS_Taipei--Trip1.png">
                                    <figure class = "col-sm-12">
+
<p><b>Dr. Li Guo Min </b> Veterinarian at Nicholas Animal Hospital</p>
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
+
                                    <figcaption class='darkblue'><b>Photo at Interview </b>Full Construct.</figcaption>
+
 
                                 </figure>
 
                                 </figure>
 
                                  
 
                                  
Line 363: Line 363:
 
                             </div>
 
                             </div>
 
                           <br><br>
 
                           <br><br>
                            <div class="row">
 
                                                               
 
                               
 
                            </div>
 
 
                             <div class="row">
 
                             <div class="row">
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
 
                                     <h3 id="ConstructPrevention"></h3>
 
                                     <h3 id="ConstructPrevention"></h3>
 
                                         <br>
 
                                         <br>
                                     <h4>Science Researchers</h4>
+
                                     <h4>Contact with Science Researchers</h4>
 
                                     <p>
 
                                     <p>
                                         Researchers’ firsthand knowledge, regardless of how many papers one reads on PubMed, provides a better understanding on the topic of research. Thus, in order to gain a better view of our project, we have contacted professional researchers ,via email, who have in depth knowledge on 25 hydroxycholesterol, which is the main candidate for the cause of formation of cataracts.  
+
                                         Researchers’ firsthand knowledge, regardless of how many papers one reads on PubMed, provides a better understanding on specific topics of research. Thus, in order to gain a better understanding of specific areas of our project, we contacted researchers to learn more about 25-hydroxycholesterol (25HC) and Chitosan nanoparticles.  
  
 
                                     </p>
 
                                     </p>
Line 379: Line 375:
 
                           </div>
 
                           </div>
 
                             <div class="row">
 
                             <div class="row">
                                 <figure class = "col-sm-6">
+
                                 <div class="col-sm-12">
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
+
                                    <div class="row">
                                    <figcaption class='darkblue'><b>Dr.  Jason Cyster </b>is a professor of Microbiology and Immunology at University of California, San Francisco; School of Medicine.</figcaption>
+
                                        <figure class = "col-sm-3">
                                </figure>
+
                                        <img src="https://static.igem.org/mediawiki/2016/5/5e/T--TAS_Taipei--Doctor3.png">
                                <figure class = "col-sm-6">
+
                                        </figure>
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
+
                                        <div class="col-sm-3">
                                    <figcaption class='darkblue'><b>Dr. Jason E. Gestwicki </b>is an associate professor in the Department of Institute of Neurodegenerative Diseases at University of California, San Francisco; School of Medicine. </figcaption>
+
                                            <p>
                                </figure>
+
                                                <b>Dr.  Jason Cyster </b>is a professor of Microbiology and Immunology at University of California, San Francisco; School of Medicine.  
                               
+
                                            </p>
                                  
+
                                        </div>
                            </div>
+
                                        <figure class = "col-sm-3">
 +
                                        <img src="https://static.igem.org/mediawiki/2016/b/b6/T--TAS_Taipei--Doctor4.png">
 +
                                        </figure>
 +
                                        <div class="col-sm-3">
 +
                                            <p>
 +
                                                <b>Dr. Jason E. Gestwicki </b>is an associate professor in the Department of Institute of Neurodegenerative Diseases at University of California, San Francisco; School of Medicine.  
 +
                                            </p>
 +
                                        </div>
 +
                                    </div>
 +
                                   
 +
                                   
 +
                                 </div>
 +
                          </div>
 +
                    <br><br>
 
                           <div class="row">
 
                           <div class="row">
 
                               <div class="col-sm-12">
 
                               <div class="col-sm-12">
                                  <p>Our questions were primarily focused on how 25HC works on the molecular level. We asked questions such as: what are the current researches conducted that uses 25HC?  To what extent is 25 HC responsible for reversing protein aggregation? And what are effective methods for 25HC storage?  Both professors gave thorough responses on these questions, which we then used to support our choice of methods. One response that was particularly helpful from Dr. Cyster was his suggestions on effective ways to store 25HC, in which he provided us with a recommended storage temperature. On the other hand Dr. Gestwicki provided us with two published papers that addressed our concerns about 25HC, and this helped elucidate our understanding of 25HC. </p>
+
                                    <p>Our questions were primarily focused on how 25HC works on the molecular level. We asked questions such as: what are the current researches conducted that uses 25HC?  To what extent is 25HC responsible for reversing protein aggregation? And what are effective methods for 25HC storage?  Both professors gave thorough responses on these questions, which we then used in our experiments. One response that was particularly helpful from Dr. Cyster was his suggestions on effective ways to store 25HC, in which he provided us with a recommended storage temperature. Dr. Gestwicki also provided us with two published papers that helped us understand the mechanism by which 25HC reverses cataract formation and this helped elucidate our understanding of 25HC.</p>
                              </div>
+
                            </div>  
                          </div>
+
                        </div>
 +
                            <div class="row">
 +
                                <div class="col-sm-12">
 +
                                    <h4>Contact with Nanoparticle Engineers</h4>
 +
                                        <figure class = "col-sm-3">
 +
                                        <img src="https://static.igem.org/mediawiki/2016/4/48/T--TAS_Taipei--Doctors6.png">
 +
                                        </figure>
 +
                                        <div class="col-sm-9">
 +
                                            <p>
 +
                                                We met with <b>Dr. Eric P. Lee</b>, Senior member of Technical Staff at Maxim Integrated, and TAS alumnus, to discuss issues we were having concerning chitosan nanoparticles.  Specifically we had difficulty obtaining SEM images and with nanoparticle formation.  His advice on the specific order of adding TPP to chitosan helped us make consistent nanoparticles.  Additionally, he explained why we kept seeing large amorphous structures in our SEM images: a charge buildup in the nanoparticles from the electron beam. We used this information to improve our prototype and obtain quality images from both SEM and AFM.
 +
                                            </p>
 +
                                        </div> 
 +
                                </div>
 +
                            </div>
 +
 
 
                           <br><br>
 
                           <br><br>
 
                           <div class="row">
 
                           <div class="row">
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
                                  
+
                                 <h3 id="public"></h3>
                                <h3 id="ConstructPrevention">Public Opinion</h3>
+
                                <br>
 +
                                <h3>Public Opinion</h3>
 
                                         <br>
 
                                         <br>
 
                                     <h4>Bioethics Panel</h4>
 
                                     <h4>Bioethics Panel</h4>
 
                                     <p>
 
                                     <p>
                                         We hosted a bioethics panel, where we invited teachers from various fields to engage in a conversation about bioethics and thoughts on our project in particular. The reason for including teachers from different fields is to allow our project and the topic of bioethics to be discussed from different aspects. Since we did this at the start of our project, the opinions shared and advice given during the panel shaped the direction of our project.   
+
                                         We hosted a bioethics panel, where we invited teachers from various fields to engage in a conversation about bioethics and thoughts on our project in particular. The reason for including teachers from different fields is to allow our project and the topic of bioethics to be discussed from different perspectives. The panelists suggested that our project could really be applicable for use in dogs and cats. They also seemed unafraid of our use of nanoparticles, mainly due to the fact that they are biodegradable.   
  
 
                                     </p>
 
                                     </p>
Line 410: Line 434:
 
                             <div class="row">
 
                             <div class="row">
 
                                 <figure class = "col-sm-6">
 
                                 <figure class = "col-sm-6">
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
+
     
                                     <figcaption class='darkblue'><b>Dr.  Jason Cyster </b>is a professor of Microbiology and Immunology at University of California, San Francisco; School of Medicine.</figcaption>
+
        <img src="https://static.igem.org/mediawiki/2016/f/f7/T--TAS_Taipei--EthicsPanel.png">
 +
                                      
 +
                                </figure>
 +
                                   
 
                                 </figure>
 
                                 </figure>
 
                                 <figure class = "col-sm-6">
 
                                 <figure class = "col-sm-6">
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
+
        <img src="https://static.igem.org/mediawiki/2016/6/6a/T--TAS_Taipei--TeamPhotoHP.png">
                                    <figcaption class='darkblue'><b>Dr. Jason E. Gestwicki </b>is an associate professor in the Department of Institute of Neurodegenerative Diseases at University of California, San Francisco; School of Medicine. </figcaption>
+
                             
 
                                 </figure>
 
                                 </figure>
 
                                  
 
                                  
Line 424: Line 451:
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
 
                              
 
                              
                                     <h4>Survey</h4>
+
                                     <h4>Cataract Survey</h4>
 
                                     <p>
 
                                     <p>
                                         During TAS’s Spring Fair we conducted a survey, from which we derived a general sense of how willing people are going to buy products that are produced by GMOs, and our eyedrops in specific.
+
                                         During TAS’s Spring Fair and our Taipei Cataract Awareness Day, we conducted a survey, from which we derived a general public sense of the following: <br>
 +
<UL>
 +
<LI>Understanding of cataracts </li>
 +
<LI>Willingness to use GMO products </li>
 +
<LI>Willingness to use our product in humans and pets </li>
 +
<LI>Side effect tolerance </li>
 +
<LI>Willingness to pay for cataract surgery </li>
 +
</UL>
 
                                     </p>
 
                                     </p>
 
                                 </div>
 
                                 </div>
 +
                              <a href="https://static.igem.org/mediawiki/2016/b/bf/T--TAS_Taipei--iGEM_Survey_2016_-_Google_Forms.extension.pdf"><button type="button" class="btn btn-primary btn-lg">Click to download our survey results!</button></a>
 
                           </div>
 
                           </div>
 
                              
 
                              
Line 434: Line 469:
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
 
                              
 
                              
                                     <h4>Interviews with Cataracts Patients</h4>
+
                                     <h4>Interviews with Cataract Patients</h4>
 
                                     <p>
 
                                     <p>
                                         We did interviews with two cataracts patients about their past experiences in different cataracts treatment, and extracted this information along with the responses from survey, and incorporated into some of the ideas in our marketing plan. Something in common that the two people we interviewed had was that they both suffered from inconveniences due to the lens options, which would either make one nearsighted or farsighted. Furthermore, complications due to the surgery varied among individual cases; one suffered from dryness and irritation of the eye, while the other had no complications at all. Nevertheless, both of them stated that the surgery process was efficient and effective; however, if given the choice to apply effective eye drops instead of surgery, they’d be willing to use it despite some may fear the idea of having nanoparticles in one's eyes.
+
                                         We interviewed two former cataract patients about their experiences with surgery. Both patients suffered from inconveniences due to the synthetic lens options, which would either make one nearsighted or farsighted. Complications due to surgery varied among individual cases; one suffered from dryness and irritation of the eye, while the other had no complications at all. Both of them stated that the surgery process was efficient and effective; however, if given the choice to apply effective eye drops instead of surgery, they’d be willing to use it rather than face surgery again. Dr. Moran’s and Mrs. Clapper’s experiences reinforce the disadvantages of surgery, and further motivated us to create a non-invasive solution.  
 
                                     </p>
 
                                     </p>
 +
                                    <a href="https://static.igem.org/mediawiki/2016/8/85/T--TAS_Taipei--Dr.moraninterview.pdf"><button type="button" class="btn btn-primary btn-lg">Click to see our interview with Dr. Catriona Moran</button></a> <br><br>
 +
                                    <a href="https://static.igem.org/mediawiki/2016/2/2d/T--TAS_Taipei--Mrs.clapperinterview.pdf"><button type="button" class="btn btn-primary btn-lg">Click to see our interview with Mrs. Sharon Clapper</button></a>
 +
                                    <br><br>
 
                                 </div>
 
                                 </div>
 
                           </div>
 
                           </div>
 +
                          <div class="row">
 +
                                <div class="col-sm-3">
 +
                                    <p><br><br>
 +
                                    <b>Dr. Catriona Moran </b>is a former patient of cataract surgery
 +
                                    </p>
 +
                              </div>
 +
                                <figure class = "col-sm-3">
 +
        <img src="https://static.igem.org/mediawiki/2016/f/f7/T--TAS_Taipei--Patient1.png">
 +
                                </figure>
 +
                              <div class="col-sm-3">
 +
                                    <p><br><br>
 +
                                    <b>Mrs. Sharon Clapper </b>is a former patient of cataracts surgery
 +
                                    </p>
 +
                              </div>
 +
                           
 +
                                <figure class = "col-sm-3">
 +
        <img src="https://static.igem.org/mediawiki/2016/d/d3/T--TAS_Taipei--Patient2.png">
 +
                                </figure>
 +
                               
 +
                               
 +
                            </div>
 
                            
 
                            
 
                            
 
                            
Line 451: Line 510:
 
                     <div class = "row">
 
                     <div class = "row">
 
              <div class="col-sm-12">
 
              <div class="col-sm-12">
        <h2 id = 'construct'>Education and Outreach</h2>
+
        <h2 id = 'outreach'>Outreach</h2>
 
                             <div class="row">
 
                             <div class="row">
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
 
                                     <p>
 
                                     <p>
                                     Science is often intimidating to many, but with little explanation and some experience, it isn’t scary at all. Thus, aside from the goal to raise awareness of cataracts, the promotion of science and synthetic biology in particular, are also topics we aim elucidate.  Here are a list of activities and programs that serve our purpose.  
+
                                     From interviews with cataract patients, ophthalmologists, veterinarians, polls from residents in Taipei and our school community, we learned that cataracts are prevalent and have a huge impact on everyday life. Now we wanted to raise awareness through education. We started by informing teachers and students of various grade levels about the severity and causes of cataracts, and how our project could tackle these problems.  
 
                                     </p>
 
                                     </p>
 +
                                    <p>Then, in our community, we handed out pamphlets, taught people how cataracts form, and simulated a cataract experience by wearing goggles of varying cloudiness.  Below is a list of activities and programs that we did in outreach.  </p>
 +
                                   
 
                                 </div>
 
                                 </div>
 
                           </div>
 
                           </div>
 +
                          <div class="row">
 +
                                <h3>Spring Fair</h3>
 +
                                <div class="col-sm-6">
 +
                                <h3 id="ConstructPrevention"></h3>                           
 +
                                <p>
 +
                                    This is a photo of a lower school student at our booth, playing our interactive game and learning about what it is like to have cataracts.
 +
                                </p>
 +
                                <p>During Spring Fair we conducted a survey to gather public opinion and designed an interactive game to raise awareness of cataracts. In the survey we asked questions regarding people’s opinions on genetically modified organisms, cataract surgery, and our project. For the game we taped parafilm onto lab goggles and asked people who came to our booth to play the “piano tiles” app with those goggles on, and thus experiencing a real life simulation of the effects of cataracts on vision. </p>
 +
                                </div>
 +
                              <figure class = "col-sm-6">
 +
        <img src="https://static.igem.org/mediawiki/2016/7/70/T--TAS_Taipei--SpringFairHP.png">
 +
                                </figure>
 +
                             
 +
                               
 +
                            </div>
 +
                          <div class="row">
 +
                               
 +
                                <div class="col-sm-12">
 +
                                <h3 id="ConstructPrevention"></h3>
 +
                                    <br>
 +
                                <h3>Taipei Cataract Awareness Day</h3>
 +
                                <p>Our team went on an excursion to five different landmarks in Taipei and passed out flyers containing information on cataracts to the general public. We explained the formation of cataracts and the basic concepts of our project to local crowds and asked them to fill out our survey to get a wider sample size. 
 +
</p>
 +
                                    <a href="https://www.youtube.com/watch?v=kLJ8-ZtYwg8"><button type="button" class="btn btn-primary btn-lg">Click to watch our Excursion!</button></a>
 +
                                </div>
 +
                               
 +
                            </div>
 
                             <div class="row">
 
                             <div class="row">
 
                                  
 
                                  
Line 464: Line 552:
 
                                 <h3 id="ConstructPrevention"></h3>
 
                                 <h3 id="ConstructPrevention"></h3>
 
                                     <br>
 
                                     <br>
                                 <h3>Prevention: GSR-HIS</h3>
+
                                 <h3>Kindergarten Science Experiments</h3>
 
                                 <p>
 
                                 <p>
                                     Science is often intimidating to many, but with little explanation and some experience, it isn’t scary at all. Thus, aside from the goal to raise awareness of cataracts, the promotion of science and synthetic biology in particular, are also topics we aim elucidateHere are a list of activities and programs that serve our purpose.
+
                                     We designed some easy experiments so that Kindergarten students could explore some common science concepts.  The kids (and our team members) loved it!  Some of the experiments included how to use the microscope, why light reflects through prisms, and how static electricity works.   
 
                                 </p>
 
                                 </p>
 
                                 </div>
 
                                 </div>
 +
                                <a href="https://vimeo.com/153454343"><button type="button" class="btn btn-primary btn-lg">Click to watch the Kindergarden video!</button></a>
 
                                  
 
                                  
 
                             </div>
 
                             </div>
Line 474: Line 563:
 
                             <div class="row">
 
                             <div class="row">
 
                                 <figure class = "col-sm-6">
 
                                 <figure class = "col-sm-6">
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
+
        <img src="https://static.igem.org/mediawiki/2016/0/08/T--TAS_Taipei--Kinder1.png">
                                    <figcaption class='darkblue'><b>Figure X. </b>Full Construct.</figcaption>
+
 
                                 </figure>
 
                                 </figure>
 
                                 <figure class = "col-sm-6">
 
                                 <figure class = "col-sm-6">
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
+
        <img src="https://static.igem.org/mediawiki/2016/7/74/T--TAS_Taipei--Kinder3.png">
                                    <figcaption class='darkblue'><b>Figure X. </b>Full Construct.</figcaption>
+
                                </figure>
+
                            </div>
+
                          <div class="row">
+
                                <figure class = "col-sm-6">
+
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
+
                                    <figcaption class='darkblue'><b>Figure X. </b>Full Construct.</figcaption>
+
                                </figure>
+
                                <figure class = "col-sm-6">
+
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
+
                                    <figcaption class='darkblue'><b>Figure X. </b>Full Construct.</figcaption>
+
 
                                 </figure>
 
                                 </figure>
 
                             </div>
 
                             </div>
 +
                         
 
                           <br><br>
 
                           <br><br>
 +
 
                             <div class="row">
 
                             <div class="row">
 
                                  
 
                                  
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
                                  
+
                                 <h3 id="ConstructPrevention"></h3>
                                 <p>
+
                                    <br>
                                  We designed some easy experiments to let the Kindergarten students try playing with. We did this for several times, and the kids loved it. The experiments were usually very simple yet demonstrates important scientific concepts, for instance, we teached them how to use the microscope, why light reflects through prisms, how static electricity works etc.
+
                                 <h3>7th Grade Introduction to Synthetic Biology</h3>
                                </p>
+
                                    <p>
 +
                                        For 7th Graders we decided to introduce the concepts of synthetic biology, since they had just be introduced to DNA in their science classes. Aside from teaching a general idea of what synthetic biology is, we also introduced them to some basic laboratory techniques essential to synthetic biology. We made up scenarios and asked them to solve these problems using different combinations of standardized parts (promoter, RBS, different ORFs, etc.). They also learned how to use micropipettes and run a gel!
 +
                                    </p>
 +
                                    <a href="https://www.youtube.com/watch?v=JtgFyzSYF-I"><button type="button" class="btn btn-primary btn-lg">Click to watch 7th grade teaching!</button></a>
 
                                 </div>
 
                                 </div>
 
 
                                  
 
                                  
 
                             </div>
 
                             </div>
 
                           <br><br>
 
                           <br><br>
                         
 
 
                             <div class="row">
 
                             <div class="row">
                                <div class="col-sm-2"></div>
+
                                 <figure class = "col-sm-6">
                               
+
        <img src="https://static.igem.org/mediawiki/2016/8/8e/T--TAS_Taipei--Seven1.png">
                                 <figure class = "col-sm-8">
+
        <img src="https://static.igem.org/mediawiki/2016/3/35/T--TAS_Taipei--GSR_PCR_Check_Experimental.jpg">
+
                                    <figcaption class='darkblue'><b>Figure AA. </b>1kb ladder, GSR alone, samples after are K880005 + GSR PCR checks. Boxed bands are correct (slightly higher than GSR alone)</figcaption>
+
 
                                 </figure>
 
                                 </figure>
 
                                <div class="col-sm-2"></div>
 
                               
 
                            </div>
 
                          <br><br>
 
                          <h3 id="ConstructTreatment"></h3>
 
                          <br>
 
                          <h3>Treatment: CH25H-HIS</h3>
 
                          <div class="row">
 
                                <div class="col-sm-3"></div>
 
 
                                 <figure class = "col-sm-6">
 
                                 <figure class = "col-sm-6">
        <img src="https://static.igem.org/mediawiki/2016/a/a1/T--TAS_Taipei--CH25H_Construct_Experimental.jpg">
+
        <img src="https://static.igem.org/mediawiki/2016/8/8b/T--TAS_Taipei--Seven3.png">
                                    <figcaption class='darkblue'><b>Figure ???. </b>Caption not provided!!!</figcaption>
+
 
                                 </figure>
 
                                 </figure>
                                <div class="col-sm-3"></div>
 
 
                             </div>
 
                             </div>
                         
 
 
                           <br><br>
 
                           <br><br>
 +
                       
 
                           <div class="row">
 
                           <div class="row">
 
                                  
 
                                  
                                 <div class="col-sm-12">
+
                                 <div class="col-sm-6">
                                 <p>
+
                                 <h3 id="ConstructPrevention"></h3>
                                    We want to extract alpha crystallin B protein, one of the main proteins in the lens, to see if we can create the same aggregation as cataracts lenses.The construct here contains similar components, except the open reading is replaced by CRYAB and 10x Histidine tag. We wanted to express CRYAB, one of the two main crystallin proteins in the lens, to test if h2o2 can aggregate crystallin proteins. CRYAB cDNA was ordered from Origene. We designed primers that were synthesized by Tri-I biotech to move CRYAB into iGEM backbone. The full construct is shown in figure #. 
+
                                </p>
+
                                </div>       
+
                         
+
 
+
                        </div>
+
                          <br><br>
+
                          <div class="row">
+
                                <div class="col-sm-1"></div>
+
                                <figure class = "col-sm-4">
+
        <img src="https://static.igem.org/mediawiki/2016/c/ce/T--TAS_Taipei--ProteinGelFiona_Experimental.png">
+
                                    <figcaption class='darkblue'><b>Figure ???. </b>Caption not provided!!!</figcaption>
+
                                </figure>
+
                              <div class="col-sm-2"></div>
+
                                <figure class = "col-sm-4">
+
 
                                     <br>
 
                                     <br>
        <img src="https://static.igem.org/mediawiki/2016/f/f7/T--TAS_Taipei--CRYAB-HIS-Gel-1.png">
+
                                <h3>
                                    <figcaption class='darkblue'><b>Figure ???. </b>Caption not provided!!!</figcaption>
+
                                    International baccalaureate 11th grade</h3>
 +
                                    <p>
 +
                                        We presented our project to 11th grade IB students. Since they were learning about genetic engineering concepts, we gave a presentation on the details of our project to gain feedback.
 +
                                    </p>
 +
                                </div>
 +
                                <figure class = "col-sm-6">
 +
        <img src="https://static.igem.org/mediawiki/2016/4/4a/T--TAS_Taipei--IBSL1.png">
 
                                 </figure>
 
                                 </figure>
                              <div class="col-sm-1"></div>
+
                               
                        </div>
+
                            </div>
                    </div>
+
                                <div class="row">
                    </div>
+
                    <br><br>
+
                   
+
               
+
                    <div class = "row">
+
              <div class="col-sm-12">
+
        <h2 id = 'prototype'>Impact</h2>
+
                            <div class="row">
+
 
                                  
 
                                  
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
                                 <p>
+
                                 <h3 id="ConstructPrevention"></h3>
                                     The current method of treatment for cataracts is surgery, which is not only invasive and costly, but also possibly unavailable in areas with limited medical facilities. Taking biosafety, cost, and delivery effectiveness into account, we designed and built a prototype with two distinct steps. First, proteins must be purified and separated from bacteria, and then packaged in nanoparticles that aid delivery through the cornea and into the lens.
+
                                     <br>
                                </p>
+
                                <h3>Biobuilder Club</h3>
 +
                                    <p>
 +
                                        23 high school teams from around the world joined the BioBuilder Club, which is run by the BioBuilder Educational Foundation. This club held online meetings once a month so the teams could brainstorm synthetic biology project topics, project design, and collectively troubleshoot problems encountered by each team. The club held a final assembly in Boston at Lab Central, and we were excited to present our poster in absentia from Taipei.
 +
                                    </p><br><br>
 +
                                    <a href="http://biobuilder club.org/"><button type="button" class="btn btn-primary btn-lg">Click to join Biobuilder Club!</button></a>
 +
<br><br>
 +
                                    <a href="http://tasbiobuilder.weebly.com/"><button type="button" class="btn btn-primary btn-lg">Click to visit our Biobuilder Club webpage!</button></a>
 +
<br><br>
 
                                 </div>
 
                                 </div>
 
                                  
 
                                  
 +
                                </p>
 +
                                </div>
 
                             </div>
 
                             </div>
                             <div class="row">
+
                             <figure class = "col-sm-12">
 +
        <img src="https://static.igem.org/mediawiki/2016/b/b5/T--TAS_Taipei--Biobuilder.png">
 +
                                </figure>
 +
                               
 +
                          <div class="row">
 
                                  
 
                                  
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
                                 <h3 id="step1"></h3>
+
                                 <h3 id="ConstructPrevention"></h3>
 
                                     <br>
 
                                     <br>
                                 <h3>Step 1: His-Tag Protein Purification</h3>
+
                                 <h3>Science Research Symposium  </h3>
                                <p>
+
                                    <p>
                                    Our survey results show that people are reluctant to put anything bacteria-related into their bodies, so we aimed to separate our protein products from the bacteria that produced them. Once isolated, pure proteins can be directly used to avoid introducing foreign bacteria into our bodies. As shown in Figure A, both constructs for prevention and treatment include a downstream 10x histidine tag. The encoded GSR-HIS or CH25H-HIS proteins can then be isolated using a commercial kit (Capturem His-tagged Purification Miniprep Kit from Clontech).
+
                                        During the school year when we were brainstorming for potential project ideas, our team members were divided into several groups and gave presentations on those topics at the school’s Science Research Symposium.  Over 80 students from 11 research classes presented their own research from all different areas to the school community. This allowed us to receive feedback on our project ideas from both students and teachers. This really helped us decide our final project idea. 
                                </p>
+
                                    </p>
 +
                                    <a href="https://vimeo.com/148193740"><button type="button" class="btn btn-primary btn-lg">Click to watch the symposium poster session!</button></a>
 +
                                    <a href="https://www.youtube.com/watch?v=0TjGFL1X4VM"><button type="button" class="btn btn-primary btn-lg">Click to watch the symposium oral presentation!!</button></a>
 +
<br>
 +
<h3>Research Speaker Series  </h3>
 
                                 </div>
 
                                 </div>
                                  
+
                                  </div>
 +
                          <div class="col-sm-12">
 +
                                 <h3 id="ConstructPrevention"></h3>
 +
                                  <p>
 +
                                        We invited two science researchers to come to our school and give presentations on their research. This allowed us to learn how scientists conduct actual scientific research and also expanded our knowledge in other areas of science. Below are the science researchers that came. 
 +
                                    </p>
 
                             </div>
 
                             </div>
                           <br><br>
+
                           <div class="row">
                            <div class="row">
+
                                 <figure class = "col-sm-6">
                                <div class="col-sm-1"></div>
+
        <img src="https://static.igem.org/mediawiki/2016/1/1e/T--TAS_Taipei--DrChangSymposium.png">
                                 <figure class = "col-sm-5">
+
                                     <figcaption class='darkblue'><b>Dr. Ying Chih Chang </b>, Research Fellow and Professor, Genomics Research Center, Academia Sinica</figcaption>
        <img src="https://static.igem.org/mediawiki/2016/6/67/T--TAS_Taipei--GSR_Construct_Experimental.jpg">
+
                                     <figcaption class='darkblue'><b>Figure A. </b>Both GSR and CH25H constructs include a downstream 10x Histidine tag (in yellow) that can be used for purification using a commercial kit.</figcaption>
+
 
                                 </figure>
 
                                 </figure>
                                <div class="col-sm-1"></div>
+
                                 <figure class = "col-sm-6">
                                 <figure class = "col-sm-5">
+
        <img src="https://static.igem.org/mediawiki/2016/d/dc/T--TAS_Taipei--DrHsuSympo.png">
        <img src="https://static.igem.org/mediawiki/2016/9/9a/T--TAS_Taipei--CryABvsHis_B_Prototype.png">
+
                                     <figcaption class='darkblue'><b>Dr. Chia-Lin Hsu, Assistant Professor</b>, National Yang Ming University, Institute of Microbiology and Immunology</b>Full Construct.</figcaption>
                                     <figcaption class='darkblue'><b>Figure ???. </b>???</figcaption>
+
 
                                 </figure>
 
                                 </figure>
 +
                            </div>
 +
                          <div class="col-sm-12">
 +
                                <h3 id="ConstructPrevention"></h3>
 +
                                    <br>
 +
                                 
 +
                                </div>
 +
                        <div class="row">
 
                                  
 
                                  
 +
                                <div class="col-sm-6">
 +
                                <h3 id="ConstructPrevention"></h3>
 +
                                <h3>Club</h3>
 +
                                    <p>
 +
                                        The iGEM Club was established 3 years ago, and the purpose of is to raise awareness of synthetic biology in the TAS community. Club activities allow underclassmen to experience iGEM-related activities and develop potential team members. 
 +
                                    </p>
 +
                                </div>
 +
                            <figure class = "col-sm-6">
 +
        <img src="https://static.igem.org/mediawiki/2016/b/b3/T--TAS_Taipei--clubfair.JPG">
 +
                                </figure>
 
                                  
 
                                  
 
                             </div>
 
                             </div>
 
                           <br><br>
 
                           <br><br>
                          <h3 id="step2"></h3>
+
                        <h3>Facebook/Twitter</h3>
                                    <br>
+
                            <div class="row">
                          <h3>Step 2: Packaging in Nanoparticles</h3>
+
                                <div class="col-sm-3"></div>
 +
                                <figure class = "col-sm-6">
 +
        <img src="https://static.igem.org/mediawiki/2016/4/45/T--TAS_Taipei--FBTwitter.png">
 +
                                </figure>
 +
                                <div class="col-sm-3"></div>                             
 +
                                <a href="https://www.facebook.com/IGEM-TAS_Taipei-458152184340374/"><button type="button" class="btn btn-primary btn-lg">Click to visit our Facebook page!</button></a>  <a href="https://twitter.com/igem_tas"><button type="button" class="btn btn-primary btn-lg" align="right">Click to visit our Twitter page!</button></a>
 +
                            </div>
 
                           <div class="row">
 
                           <div class="row">
 
                                  
 
                                  
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
                                 <p>
+
                                 <h3 id="ConstructPrevention"></h3>
                                     The cornea is the outermost layer of the eye which protects the eye by preventing entry of foreign materials, but this function also largely prevents drugs from reaching the lens (Gaudana et al., 2010). This problem has challenged researchers and driven them to search for a way to deliver drugs through the cornea and into the lens. Currently, the most promising ocular drug delivery method is using chitosan nanoparticles as drug carriers (Cholkar et al., 2013).  
+
                                     <br>
                                </p>
+
                                <h3>Collaborations with Other iGEM Teams</h3>
                                </div>
+
                                    <p>
                              <div class="col-sm-12">
+
                                  We collaborated  with two iGEM teams, National Yang Ming University (NYMU) and American School in Japan (ASIJ). We mentored the ASIJ-Tokyo high school iGEM team, which is a new High school iGEM team this year. We taught them how to start and structure a new team, what lab and online resources to use for experiments, and how to set up a lab notebook. In return, they helped us test our nanoparticle calculator by running simulations from the standpoint of a patient, doctor, and manufacturer.  
                                <p>
+
                                    </p>
                                    We selected chitosan as the optimal material to make nanoparticles for several reasons. First, chitosan nanoparticles can embedded in and adhere to the cornea, this minimizes drainage loss. Also, these nanoparticles can penetrate the cornea and deliver the drug directly to the target area via (Campos et al., 2005). Its low toxicity to somatic cells makes it safe, and its biodegradability allows the drug to be released continuously in the eye (Enriquez de Salamanca et al., 2006).
+
                                    <p>We also continued our long standing partnership with National Yang Ming University (NYMU_Taipei). Three students from our team have been interning on the NYMU-Taipei team (they are members to both teams) to learn about synthetic biology and some basic lab techniques.  Two of these students will be presenting for the NYMU_Taipei team presentation. NYMU-Taipei also hosted a summer camp for our team members, where they taught us about different aspects of iGEM. In return, we helped them increase the efficiency of their model using equations from their literature research and ran simulations using their experimental data. Finally, they also gave tremendous advice on troubleshooting our cloning procedure during the summer months when we ran the majority of our wet lab experiments. We really value the relationship we have with NYMU and look forward to more collaborations in the future.</p>
                                </p>
+
                                    <p>These collaborations not only created opportunities for us to help each other with problems, but also allowed us to exchange ideas and stimulate creativity. It is also fun to share stories about lab work, successes, and even failures.</p>
 
                                 </div>
 
                                 </div>
 
                                  
 
                                  
 
                             </div>
 
                             </div>
                         
 
 
                           <br><br>
 
                           <br><br>
                          <div class="row">
+
                            <div class="row">
                               
+
 
                                 <figure class = "col-sm-6">
 
                                 <figure class = "col-sm-6">
        <img src="https://static.igem.org/mediawiki/2016/4/41/T--TAS_Taipei--PurificationAnimation.gif">
+
        <img src="https://static.igem.org/mediawiki/2016/a/a5/T--TAS_Taipei--NYMU_Summer_Camp.JPG">
                                    <figcaption class='darkblue'><b>Figure C. </b>Extracted and purified CH25H and GSR with 10x Histidine tag (in yellow) encapsulated in nanoparticles to aid delivery to the lens.</figcaption>
+
 
                                 </figure>
 
                                 </figure>
 
                                 <figure class = "col-sm-6">
 
                                 <figure class = "col-sm-6">
                                    <br><br>
+
        <img src="https://static.igem.org/mediawiki/2016/6/66/T--TAS_Taipei--teamphoto2.jpg">
        <img src="https://static.igem.org/mediawiki/2016/4/4e/T--TAS_Taipei--NPAnimation.gif">
+
                                    <figcaption class='darkblue'><b>Figure C. </b>Nanoparticles containing GSH and CH25H embed into the cornea and degrade. The released proteins are then delivered to the cornea via a concentration gradient.</figcaption>
+
 
                                 </figure>
 
                                 </figure>
                             </div>                        
+
                             </div>
                         
+
 
                          <br><br>
+
                    </div>
 +
                                   
 +
               
 +
                    <div class = "row">
 +
              <div class="col-sm-12">
 +
        <h2 id = 'impact'>Impact</h2>
 +
                           
 
                           <div class="row">
 
                           <div class="row">
                                 <div class="col-sm-5">
+
                                <h3 id="marketing"></h3>
 +
                                    <h3>Counteracts Marketing Plan</h3>
 +
                                 <div class="col-sm-8">
 +
                               
 
                                 <p>
 
                                 <p>
                                     We dissolved chitosan into 1% by volume glacial acetic acid aqueous solution.
+
                                     With the help of our business and economics teacher, we developed a comprehensive marketing plan for our cataract prevention and treatment products, in order to create a more profound impact in terms of public awareness of cataracts. Within this plan we performed a situational analysis based on market research, customer analysis, environmental/industrial considerations, and regulatory constraints (such as quality control and SWOT analysis). Furthermore, we statistically analyzed our products’ viability in the market by developing pricing and promotional strategies. Upon completion, we initiated discussions with several biotechnology investors and published our plan on business starter websites to garner interest.</p>
                                    We adjusted the pH of the chitosan solution to 5.5 by adding 1M NaOH in order to account for the stability of the desired proteins when they are added. We dissolved sodium tripolyphosphate (TPP) in distilled water. Chitosan and TPP were dissolved in equal volumes and their mass ratio was 3:1. We stirred the chitosan solution at 600 rpm while adding 3 ml of TPP solution dropwise. To collect the nanoparticles, we centrifuged the suspension at 17,000 xg for 40 minutes at 4C, and nanoparticles were collected as pellets. The specific protocol can be found in our lab notebook.  
+
                                    <p>We received constructive feedback from a former intern at RA Capital (a biotechnology investment firm). He suggested that we focus on cost projections, for it would put us in a better position to engage with venture capitalists. He also thought our competitor analysis and initial market sizing was impressive. Furthermore, this plan was shown to an opthamologist, Dr. Tai-Yuan Wang, and he suggested that with an FDA approval and clinical trials, he would be interested in our products. Thus, we can conclude that our products have the potential to compete in market.
 
                                 </p>
 
                                 </p>
 
                                 </div>
 
                                 </div>
                               <figure class = "col-sm-7">
+
                               <figure class = "col-sm-4">
        <img src="https://static.igem.org/mediawiki/2016/4/4e/T--TAS_Taipei--NPAnimation.gif">
+
        <img src="https://static.igem.org/mediawiki/2016/9/9c/T--TAS_Taipei--Impact1.png">
                                    <figcaption class='darkblue'><b>Figure C. </b>Video</figcaption>
+
<p><b>Mr. Alexander Kaufman,</b> a former intern at RA Capital (a biotechnology investment firm)<p>
 
                                 </figure>
 
                                 </figure>
 +
                               
 
                             </div>
 
                             </div>
                          <br><br>
 
 
                           <div class="row">
 
                           <div class="row">
                                 <div class="col-sm-12">
+
                               
 +
                                 <div class="col-sm-6">
 +
                                    <h3>Marketing Plan Synopsis</h3>
 
                                 <p>
 
                                 <p>
                                     To ensure our nanoparticles were correct in size and configuration, we imaged the nanoparticles using scanning electron microscopy and atomic force microscopy.  
+
                                     There exists a significant market opportunity for cataract treatment worldwide. Over 3 million cataract surgeries are performed in the United States every year, and cataracts have attributed to 51% of world blindness. Although cataract surgery is the dominant procedure in this market, we have developed a product which provides distinctive advantages, and created a marketing plan which serves as a guide for establishing a successful business.  
 
                                 </p>
 
                                 </p>
 
                                 </div>
 
                                 </div>
                            </div>
+
                            <figure class = "col-sm-6">
                          <br><br>
+
        <img src="https://static.igem.org/mediawiki/2016/f/fa/T--TAS_Taipei--MarketPlan.png">
                          <div class="row">
+
                               
                                <figure class = "col-sm-4">
+
                                 </figure>  
        <img src="https://static.igem.org/mediawiki/2016/3/30/T--TAS_Taipei--SEMChitosan%28C%29.png">
+
                               <a href="https://static.igem.org/mediawiki/2016/d/d5/T--TAS_Taipei--marketingplan.pdf"><button type="button" class="btn btn-primary btn-lg">Click to download our survey results!</button></a>
                                    <figcaption class='darkblue'><b>Figure C. </b>Scanning electron microscope image of chitosan nanoparticles</figcaption>
+
                                  
                                 </figure>
+
                               <figure class = "col-sm-8">
+
        <img src="https://static.igem.org/mediawiki/2016/2/27/T--TAS_Taipei--AtomicForceMicroscopeImage%28D%29.png">
+
                                    <figcaption class='darkblue'><b>Figure D. </b>Scanning electron microscope image of chitosan nanoparticles</figcaption>
+
                                </figure>
+
                            </div>
+
                          <br><br>
+
                          <div class="row">
+
                                <figure class = "col-sm-4">
+
        <img src="https://static.igem.org/mediawiki/2016/b/bb/T--TAS_Taipei--E-TeamLeft-Prototype.png">
+
                                    <figcaption class='darkblue'><b>Figure E.</b> Team members imaging nanoparticles on the scanning electron microscope and atomic force microscope</figcaption>
+
                                 </figure>
+
                                <div class="col-sm-1"></div>
+
                                <figure class = "col-sm-7">
+
        <img src="https://static.igem.org/mediawiki/2016/9/93/T--TAS_Taipei--E-TeamRight-Prototype.png">
+
                                    <figcaption class='darkblue'><b>Figure E.</b> Team members imaging nanoparticles on the scanning electron microscope and atomic force microscope</figcaption>
+
                                </figure>
+
 
                             </div>
 
                             </div>
 
                            
 
                            
                           <br><br>
+
                            
                          <h3 id="step2i"></h3>
+
                                    <br>
+
                          <h3>Step 2i: Protein Encapsulation</h3>
+
 
                           <div class="row">
 
                           <div class="row">
                                  
+
                                 <h3>Fundraising Efforts for Cataract Charity</h3>
 
                                 <div class="col-sm-12">
 
                                 <div class="col-sm-12">
 +
 +
                                    <h3 id="fundraising"></h3>
 +
                                    <br>
 +
 +
                                   
 
                                 <p>
 
                                 <p>
                                     Next, we wanted to load our protein into the nanoparticles. In order to  determine how successfully our nanoparticles encapsulated proteins, we measured the change in protein concentration in the supernatant before and after nanoparticle formation. By performing a Bradford Assay with the nanoparticle supernatant (Bio-Rad), we found the encapsulation efficiency to be 50%.  
+
                                     Lastly, we wanted to make a real impact in people’s lives who were experiencing cataracts. Despite our project’s goal of delivering cataract relief non-invasively, we realize that surgery is currently the most effective way to eliminate cataracts. So, we held fundraisers (in the form of bake sales and club fairs) in order to donate to those who don’t have funds or access to surgery. We raised enough money for 14 surgeries through the Himalayan Cataract Project, which serves underprivileged cataract patients.
 +
 
 
                                 </p>
 
                                 </p>
 +
                                    <a href="https://www.youtube.com/watch?v=uAQgzXTy1W4"><button type="button" class="btn btn-primary btn-lg">Click to watch our bake sale!</button></a>
 +
                                    <a href="https://static.igem.org/mediawiki/2016/f/fc/T--TAS_Taipei--himalayancataractdonation.pdf"><button type="button" class="btn btn-primary btn-lg">Click to see our contribution!</button></a>
 +
                                    <br><br>
 +
                                    <br><a href="https://donate.cureblindness.org"><button type="button" class="btn btn-primary btn-lg">Click to donate to the Himalayan Cataract Project!!</button></a>
 
                                 </div>
 
                                 </div>
                          </div>
+
                             
 +
                             
 +
                               
 +
                            </div>
 +
                         
 
                           <br><br>
 
                           <br><br>
 
                           <div class="row">
 
                           <div class="row">
                              <div class="col-sm-1"></div>
+
                               
                                 <figure class = "col-sm-10">
+
                                 <figure class = "col-sm-6">
        <img src="https://static.igem.org/mediawiki/2016/1/19/T--TAS_Taipei--F-EncapsulationGraph.png">
+
        <img src="https://static.igem.org/mediawiki/2016/e/e7/T--TAS_Taipei--Impact2.png">
                                     <figcaption class='darkblue'><b>Figure F.</b> Top left graph shows the absorbance value of the supernatant after nanoparticle formation when chitosan is added dropwise to TPP pool. Bottom left diagram show the supernatant with 3x coomassie blue on the left and the set of varying BSA concentrated supernatant with 3x coomassie blue used to make standard curve on the right. </figcaption>
+
                                      
                                <div class="col-sm-1"></div>
+
                            </div>
+
                              <br><br>
+
                            <div class="row">
+
 
                                 </figure>
 
                                 </figure>
 
                                 <figure class = "col-sm-6">
 
                                 <figure class = "col-sm-6">
        <img src="https://static.igem.org/mediawiki/2016/e/e4/T--TAS_Taipei--G-Abs-supernatant.png">
+
        <img src="https://static.igem.org/mediawiki/2016/9/9c/T--TAS_Taipei--Impact3.png">
                                    <figcaption class='darkblue'><b>Figure G.</b>Graph showing the absorbance value of the supernatant after nanoparticle formation, when chitosan is added to TPP.  </figcaption>
+
                               
 
                                 </figure>
 
                                 </figure>
                                <div class="col-sm-6">
+
                             </div>                        
                                <p>
+
                                    More BSA remained in the supernatant after nanoparticle formation when Chitosan was added to TPP. It is inferred that more proteins are encapsulated in the nanoparticles for those made from TPP added to Chitosan. 
+
                                </p>
+
                                <p>
+
                                    We synthesized nanoparticles containing fluorescent proteins to prove that our nanoparticles can be used to encapsulate our protein drugs. To do so, we lysed bacteria expressing green fluorescent protein (GFP), red fluorescent protein (RFP), and green pigment (from pGRN, Bba_K274003). We then extracted and encapsulated the proteins in nanoparticles using the procedure described above. 
+
                                </p>
+
                                </div>
+
                              
+
                          </div>
+
                          <br><br>
+
                              <div class="row">
+
                                  <div class="col-sm-1"></div>
+
                                    <figure class = "col-sm-10">
+
        <img src="https://static.igem.org/mediawiki/2016/6/66/T--TAS_Taipei--H-NPPellets_Prototype.png">
+
                                    <figcaption class='darkblue'><b>Figure H.</b>On the left are nanoparticle pellets containing GFP, RFP, and pGRN in white light; on the right are the pellets in blue light.  </figcaption>
+
                                    </figure>
+
                                  <div class="col-sm-1"></div>
+
                          </div>
+
                          <h3 id="step2ii"></h3>
+
                                    <br>
+
                          <h3>Step 2ii: Protein Release</h3>
+
                          <div class="row">
+
                               
+
                                <div class="col-sm-12">
+
                                <p>
+
                                    As nanoparticles degrade, they release the proteins inside. We measured and mathematically modeled the release rate to determine the optimal frequency of drug administration.
+
                                </p>
+
                                <p>
+
                                    To measure release rate, we suspended nanoparticles containing bovine serum albumin (BSA), our standard protein, in phosphate buffered saline (PBS).  PBS models the conditions of our cornea on which the nanoparticles that we deliver will be embedded to degrade and release the proteins. We measured protein concentration of the solution outside the nanoparticles over time. We performed trials at three different temperatures, -20C, 4C, and 37C to reflect long term storage, short term storage, and drug application.
+
                                    </p>
+
                                <p>
+
                                    Procedure for this experiment is illustrated in our lab notebook.
+
                                </p>
+
                                </div>
+
                          </div>
+
                          <h3 id="step3"></h3>
+
                                    <br>
+
                          <h3>Step 3: Application - Eye drop and Contact Lens</h3>
+
                          <div class="row">
+
                               
+
                                <div class="col-sm-12">
+
                                <p>
+
                                    We engineered nanoparticles to deliver glutathione reductase (GSR) and cholesterol 25-hydroxylase (CH25H) to the lens through a safe, cost effective, and non-invasive method. We purified the proteins from bacteria using histidine tag purification method to minimize toxicity and loaded them into nanoparticles to maximize drug delivery.  We designed two drug delivery prototypes to apply our nanoparticles: eye drops and contact lenses.
+
                                    </p>
+
                                </div>
+
                          </div>
+
 
+
 
                            
 
                            
 +
                                               
 
                            
 
                            
 
                     </div>
 
                     </div>
Line 762: Line 802:
 
                     <div class = "row">
 
                     <div class = "row">
 
  <div class="col-sm-12">
 
  <div class="col-sm-12">
<h3>Citations</h3>
+
 
        <br> <br>  <br>  <br>  <br>  <br>  <br>  <br>             
 
        <br> <br>  <br>  <br>  <br>  <br>  <br>  <br>             
 
  </div>
 
  </div>
Line 798: Line 838:
 
var nowRadius = 0
 
var nowRadius = 0
 
$(function() {
 
$(function() {
 +
    if (screen.width > 1800)
 +
      $("#slideoutco").fadeOut(0);
 
     $({blurRadius: 0}).animate({blurRadius: 10}, {
 
     $({blurRadius: 0}).animate({blurRadius: 10}, {
 
         duration: 20000,
 
         duration: 20000,
Line 846: Line 888:
 
         var NineLOCSnum = Math.round(nowRadius*6/9*10);
 
         var NineLOCSnum = Math.round(nowRadius*6/9*10);
 
         /**if (NineLOCSnum == 15) $("#slideoutco").fadeOut(400);
 
         /**if (NineLOCSnum == 15) $("#slideoutco").fadeOut(400);
         if (NineLOCSnum > 20) switchMessage("RED","<b>Cataracts</b> are creeping back again! Click the PREVENTION eyedrop to add GSR into your eyes!", currentColor()=="BLUE");*/
+
         if (NineLOCSnum > 20) switchMessage("RED","<b>Cataracts</b> are creeping back again! Click the PREVENTION eye drop to add GSR into your eyes!", currentColor()=="BLUE");*/
 
         if (LOCSnum > 6) {LOCSnum = "6+"; $('#LOCS').text(LOCSnum+"");}
 
         if (LOCSnum > 6) {LOCSnum = "6+"; $('#LOCS').text(LOCSnum+"");}
 
         else $('#LOCS').text(LOCSnum+" ");  
 
         else $('#LOCS').text(LOCSnum+" ");  
Line 1,051: Line 1,093:
 
<div id="slideoutco">
 
<div id="slideoutco">
 
     <div id="slidecontentco">
 
     <div id="slidecontentco">
         <div id="slidecontenttext" class="alert alert-danger fade in">
+
         <div id="slidecontenttext" class="alert alert-danger">
             <p style="font-size:14px !important"><a href="#" class="close" data-dismiss="alert" aria-label="close">&times;</a>
+
             <p style="font-size:14px !important"> <a href="#" class="close" data-dismiss="alert">&times;</a>
                 <strong>The tutorial is disabled.</strong> &#160; &#160; &#160; &#160; &#160;<a href="https://2016.igem.org/Team:TAS_Taipei/Wiki_Standard_Pages#Animation"><button  type="button" class="btn btn-danger btn-sm">?</button> </a><span style="font-size:14px"><br>Turn off prevention eyedrops to activate the animation. For a full tutorial, click the question mark. </span></p>
+
                 <strong>Zoom out to see animation.</strong> &#160; &#160; &#160; &#160; &#160;<a href="https://2016.igem.org/Team:TAS_Taipei/Wiki_Standard_Pages#Animation"><button  type="button" class="btn btn-danger btn-sm">?</button> </a><span style="font-size:14px"><br>Your screen resolution is too low unless you zoom out </span></p>
 
              
 
              
 
         </div>
 
         </div>
Line 1,084: Line 1,126:
 
     width: 300px;
 
     width: 300px;
 
     top: 78%;
 
     top: 78%;
     right:10px;
+
     right:1%;
 
     padding-left: 10px;
 
     padding-left: 10px;
 
     padding-right: 10px;
 
     padding-right: 10px;
Line 1,182: Line 1,224:
 
.slider.round:before {
 
.slider.round:before {
 
   border-radius: 50%;
 
   border-radius: 50%;
 +
}
 +
input[type=text] {
 +
    width: 100%;
 +
    padding: 12px 20px;
 +
    margin: 8px 0;
 +
    box-sizing: border-box;
 +
    border: 3px solid #ccc;
 +
    -webkit-transition: 0.5s;
 +
    transition: 0.5s;
 +
    outline: none;
 +
}
 +
input[type=text]:focus {
 +
    border: 3px solid #555;
 
}
 
}
 
</style>
 
</style>
Line 1,195: Line 1,250:
 
      
 
      
 
});
 
});
 +
  
  

Latest revision as of 14:26, 2 December 2016

Human Practice - TAS Taipei iGEM Wiki





Human Practice Summary

What we discovered through our findings in policy and practice helped shaped the trajectory of our project. We gathered data from researchers, medical doctors, veterinarians, cataract patients, and public opinions to find out the best way to develop our project so that it can benefit as many people as possible.

Our Policy and Practice is separated into three categories, Research, Outreach and Impact. In the Research category, we collected and analyzed data from researchers, doctors, vets, investors, patients and the general public. This information shaped the direction of every part of our project, including the construct design, nanoparticle prototype synthesis and delivery, biological modeling and the development of a marketing plan for selling our final product. In the Outreach category, we educated the public and spread awareness of our cataracts project, synthetic biology and science in general. We also collaborated and communicated with two iGEM teams to help solve problems together. Through educating and raising awareness, we hope not only to get more people involved in finding a solution to cataracts, but also to get more people involved and interested in synthetic biology research. The final category, Impact, includes working with organizations and infrastructure that is already in place to actually help people who suffer from Cataracts. We have raised funds, through bake sales and other events, to donate to the Himalayan Cataracts Project, a non-profit organization based in Nepal. With the help of our business and economics teacher, we have also created a marketing plan and started discussions with several biotech investors about the possibility of getting our project to market.

Research


Professional Help

In order to improve our research and prototype, we needed to get in contact with experts in the fields of eye surgery and cataract research. Our first step was to contact eye doctors to discuss any problems associated with current cataract treatments. Finally, while developing our project we realized that cataracts are a major issue in pets and other animals as well. As a result, we contacted local veterinarians to discuss what pet owners do when their pets develop cataracts. As our project developed, we needed more specific information regarding our genes of interest, cataract development, and our delivery mechanism. We contacted scientists doing research similar to our own to get their opinions on our projects as well.



Contact with Eye Doctors

We contacted local Taiwanese eye doctors to ask them about cataracts surgery. Here is a list of the doctors we contacted along with the information they provided:

Dr. Wei-Chi Wu is a retina specialist and an associate professor at Chang Gung memorial hospital in Taiwan.

Dr. Tsu Chieh Cheng is a opthamologist at Chang Cheng eye hospital in Taiwan.


According to Dr. Wu current cataract surgery methods are efficient and effective, but are not without their issues. Beside the high cost of surgery, there can also be several different post-surgery complications such as infection, hemorrhaging, or secondary glaucoma. In regards to our project, he said one of the biggest issues we would face is non-invasive delivery. Currently, injections and incisions are the only methods for delivery because all current potential methods of noninvasive delivery either lack efficiency or induce side effects.

Dr. Cheng points out that aside from possibly causing complications such as astigmatism, myopia, and hyperopia, cataract surgeries have risks, such as wound infections, dislodgement of lens, and massive bleeding during surgeries are not uncommon. He remarked that our project sounded very promising, but the effect that the drug has on other parts of the eye must be checked. Furthermore, he suggested that we use rabbits or dogs as animal models, because they can be observed more easily.

Contact with Veterinarians

Cataracts affect millions of people’s lives as a result of aging and diseases; however, many pet owners come across the problem of their pets suffering from cataracts as well. To alleviate this problem, we investigated if the potential benefits of our solution can be applied to domestic animals as well.

As we continued to develop our project, we also hoped to treat cataracts in animals. We consulted with veterinarians at clinics around Taipei. We visited two veterinarian clinics, (Nicholas Animal Hospital and Tai Pu Veterinarian Hospital) and asked various others about the viability of our project. From these interviews we learned that there are already commercial eye drops available, which are prescribed for pets, but that these are not very effective. One of the drugs developed is called Ocluvet(R), which we purchased and used in our experiments to compare to our own treatment design.


Dr. Li Guo Min Veterinarian at Nicholas Animal Hospital




Contact with Science Researchers

Researchers’ firsthand knowledge, regardless of how many papers one reads on PubMed, provides a better understanding on specific topics of research. Thus, in order to gain a better understanding of specific areas of our project, we contacted researchers to learn more about 25-hydroxycholesterol (25HC) and Chitosan nanoparticles.

Dr. Jason Cyster is a professor of Microbiology and Immunology at University of California, San Francisco; School of Medicine.

Dr. Jason E. Gestwicki is an associate professor in the Department of Institute of Neurodegenerative Diseases at University of California, San Francisco; School of Medicine.



Our questions were primarily focused on how 25HC works on the molecular level. We asked questions such as: what are the current researches conducted that uses 25HC? To what extent is 25HC responsible for reversing protein aggregation? And what are effective methods for 25HC storage? Both professors gave thorough responses on these questions, which we then used in our experiments. One response that was particularly helpful from Dr. Cyster was his suggestions on effective ways to store 25HC, in which he provided us with a recommended storage temperature. Dr. Gestwicki also provided us with two published papers that helped us understand the mechanism by which 25HC reverses cataract formation and this helped elucidate our understanding of 25HC.

Contact with Nanoparticle Engineers

We met with Dr. Eric P. Lee, Senior member of Technical Staff at Maxim Integrated, and TAS alumnus, to discuss issues we were having concerning chitosan nanoparticles. Specifically we had difficulty obtaining SEM images and with nanoparticle formation. His advice on the specific order of adding TPP to chitosan helped us make consistent nanoparticles. Additionally, he explained why we kept seeing large amorphous structures in our SEM images: a charge buildup in the nanoparticles from the electron beam. We used this information to improve our prototype and obtain quality images from both SEM and AFM.




Public Opinion


Bioethics Panel

We hosted a bioethics panel, where we invited teachers from various fields to engage in a conversation about bioethics and thoughts on our project in particular. The reason for including teachers from different fields is to allow our project and the topic of bioethics to be discussed from different perspectives. The panelists suggested that our project could really be applicable for use in dogs and cats. They also seemed unafraid of our use of nanoparticles, mainly due to the fact that they are biodegradable.

Cataract Survey

During TAS’s Spring Fair and our Taipei Cataract Awareness Day, we conducted a survey, from which we derived a general public sense of the following:

  • Understanding of cataracts
  • Willingness to use GMO products
  • Willingness to use our product in humans and pets
  • Side effect tolerance
  • Willingness to pay for cataract surgery

Interviews with Cataract Patients

We interviewed two former cataract patients about their experiences with surgery. Both patients suffered from inconveniences due to the synthetic lens options, which would either make one nearsighted or farsighted. Complications due to surgery varied among individual cases; one suffered from dryness and irritation of the eye, while the other had no complications at all. Both of them stated that the surgery process was efficient and effective; however, if given the choice to apply effective eye drops instead of surgery, they’d be willing to use it rather than face surgery again. Dr. Moran’s and Mrs. Clapper’s experiences reinforce the disadvantages of surgery, and further motivated us to create a non-invasive solution.







Dr. Catriona Moran is a former patient of cataract surgery



Mrs. Sharon Clapper is a former patient of cataracts surgery



Outreach

From interviews with cataract patients, ophthalmologists, veterinarians, polls from residents in Taipei and our school community, we learned that cataracts are prevalent and have a huge impact on everyday life. Now we wanted to raise awareness through education. We started by informing teachers and students of various grade levels about the severity and causes of cataracts, and how our project could tackle these problems.

Then, in our community, we handed out pamphlets, taught people how cataracts form, and simulated a cataract experience by wearing goggles of varying cloudiness. Below is a list of activities and programs that we did in outreach.

Spring Fair

This is a photo of a lower school student at our booth, playing our interactive game and learning about what it is like to have cataracts.

During Spring Fair we conducted a survey to gather public opinion and designed an interactive game to raise awareness of cataracts. In the survey we asked questions regarding people’s opinions on genetically modified organisms, cataract surgery, and our project. For the game we taped parafilm onto lab goggles and asked people who came to our booth to play the “piano tiles” app with those goggles on, and thus experiencing a real life simulation of the effects of cataracts on vision.


Taipei Cataract Awareness Day

Our team went on an excursion to five different landmarks in Taipei and passed out flyers containing information on cataracts to the general public. We explained the formation of cataracts and the basic concepts of our project to local crowds and asked them to fill out our survey to get a wider sample size.


Kindergarten Science Experiments

We designed some easy experiments so that Kindergarten students could explore some common science concepts. The kids (and our team members) loved it! Some of the experiments included how to use the microscope, why light reflects through prisms, and how static electricity works.






7th Grade Introduction to Synthetic Biology

For 7th Graders we decided to introduce the concepts of synthetic biology, since they had just be introduced to DNA in their science classes. Aside from teaching a general idea of what synthetic biology is, we also introduced them to some basic laboratory techniques essential to synthetic biology. We made up scenarios and asked them to solve these problems using different combinations of standardized parts (promoter, RBS, different ORFs, etc.). They also learned how to use micropipettes and run a gel!






International baccalaureate 11th grade

We presented our project to 11th grade IB students. Since they were learning about genetic engineering concepts, we gave a presentation on the details of our project to gain feedback.


Biobuilder Club

23 high school teams from around the world joined the BioBuilder Club, which is run by the BioBuilder Educational Foundation. This club held online meetings once a month so the teams could brainstorm synthetic biology project topics, project design, and collectively troubleshoot problems encountered by each team. The club held a final assembly in Boston at Lab Central, and we were excited to present our poster in absentia from Taipei.








Science Research Symposium

During the school year when we were brainstorming for potential project ideas, our team members were divided into several groups and gave presentations on those topics at the school’s Science Research Symposium. Over 80 students from 11 research classes presented their own research from all different areas to the school community. This allowed us to receive feedback on our project ideas from both students and teachers. This really helped us decide our final project idea.


Research Speaker Series

We invited two science researchers to come to our school and give presentations on their research. This allowed us to learn how scientists conduct actual scientific research and also expanded our knowledge in other areas of science. Below are the science researchers that came.

Dr. Ying Chih Chang , Research Fellow and Professor, Genomics Research Center, Academia Sinica
Dr. Chia-Lin Hsu, Assistant Professor, National Yang Ming University, Institute of Microbiology and ImmunologyFull Construct.


Club

The iGEM Club was established 3 years ago, and the purpose of is to raise awareness of synthetic biology in the TAS community. Club activities allow underclassmen to experience iGEM-related activities and develop potential team members.



Facebook/Twitter


Collaborations with Other iGEM Teams

We collaborated with two iGEM teams, National Yang Ming University (NYMU) and American School in Japan (ASIJ). We mentored the ASIJ-Tokyo high school iGEM team, which is a new High school iGEM team this year. We taught them how to start and structure a new team, what lab and online resources to use for experiments, and how to set up a lab notebook. In return, they helped us test our nanoparticle calculator by running simulations from the standpoint of a patient, doctor, and manufacturer.

We also continued our long standing partnership with National Yang Ming University (NYMU_Taipei). Three students from our team have been interning on the NYMU-Taipei team (they are members to both teams) to learn about synthetic biology and some basic lab techniques. Two of these students will be presenting for the NYMU_Taipei team presentation. NYMU-Taipei also hosted a summer camp for our team members, where they taught us about different aspects of iGEM. In return, we helped them increase the efficiency of their model using equations from their literature research and ran simulations using their experimental data. Finally, they also gave tremendous advice on troubleshooting our cloning procedure during the summer months when we ran the majority of our wet lab experiments. We really value the relationship we have with NYMU and look forward to more collaborations in the future.

These collaborations not only created opportunities for us to help each other with problems, but also allowed us to exchange ideas and stimulate creativity. It is also fun to share stories about lab work, successes, and even failures.



Impact

Counteracts Marketing Plan

With the help of our business and economics teacher, we developed a comprehensive marketing plan for our cataract prevention and treatment products, in order to create a more profound impact in terms of public awareness of cataracts. Within this plan we performed a situational analysis based on market research, customer analysis, environmental/industrial considerations, and regulatory constraints (such as quality control and SWOT analysis). Furthermore, we statistically analyzed our products’ viability in the market by developing pricing and promotional strategies. Upon completion, we initiated discussions with several biotechnology investors and published our plan on business starter websites to garner interest.

We received constructive feedback from a former intern at RA Capital (a biotechnology investment firm). He suggested that we focus on cost projections, for it would put us in a better position to engage with venture capitalists. He also thought our competitor analysis and initial market sizing was impressive. Furthermore, this plan was shown to an opthamologist, Dr. Tai-Yuan Wang, and he suggested that with an FDA approval and clinical trials, he would be interested in our products. Thus, we can conclude that our products have the potential to compete in market.

Mr. Alexander Kaufman, a former intern at RA Capital (a biotechnology investment firm)

Marketing Plan Synopsis

There exists a significant market opportunity for cataract treatment worldwide. Over 3 million cataract surgeries are performed in the United States every year, and cataracts have attributed to 51% of world blindness. Although cataract surgery is the dominant procedure in this market, we have developed a product which provides distinctive advantages, and created a marketing plan which serves as a guide for establishing a successful business.

Fundraising Efforts for Cataract Charity


Lastly, we wanted to make a real impact in people’s lives who were experiencing cataracts. Despite our project’s goal of delivering cataract relief non-invasively, we realize that surgery is currently the most effective way to eliminate cataracts. So, we held fundraisers (in the form of bake sales and club fairs) in order to donate to those who don’t have funds or access to surgery. We raised enough money for 14 surgeries through the Himalayan Cataract Project, which serves underprivileged cataract patients.



















Prevention

GSR Eyedrop

Treatment

25HC Eyedrop

LOCS: 0      


Eyedrops




× Zoom out to see animation.          
Your screen resolution is too low unless you zoom out